Best Income Stocks to Buy for February 7th

credit=zacks
credit=zacks

CLX, KMPR and LANC made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 7, 2023.

Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 7:

The Clorox Company CLX: This consumer and professional products company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.9% the last 60 days.

The Clorox Company Price and Consensus

The Clorox Company Price and Consensus

The Clorox Company price-consensus-chart | The Clorox Company Quote

This Zacks Rank #1 company has a dividend yield of 3.1%, compared with the industry average of 2.4%.

The Clorox Company Dividend Yield (TTM)

The Clorox Company Dividend Yield (TTM)

The Clorox Company dividend-yield-ttm | The Clorox Company Quote

Kemper Corporation KMPR: This insurance holding company has witnessed the Zacks Consensus Estimate for its next year earnings increasing 14.9% the last 60 days.

This Zacks Rank #1 company has a dividend yield of 2.2%, compared with the industry average of 2.1%.

Kemper Corporation Dividend Yield (TTM)

Kemper Corporation Dividend Yield (TTM)

Kemper Corporation dividend-yield-ttm | Kemper Corporation Quote

Lancaster Colony Corporation LANC: This food products company has witnessed the Zacks Consensus Estimate for its next year earnings increasing 4.4% the last 60 days.

This Zacks Rank #1 company has a dividend yield of 1.8%, compared with the industry average of 0.0%.

See the full list of top ranked stocks here.

 

Find more top income stocks with some of our great premium screens.

*Zacks Names "Single Best Pick to Double"

*From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

*It’s credited with a "watershed medical breakthrough" and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.

*It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
The Clorox Company (CLX): Free Stock Analysis Report
 
Kemper Corporation (KMPR): Free Stock Analysis Report
 
Lancaster Colony Corporation (LANC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

credit=zacks
credit=zacks
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018